Literature DB >> 1695204

Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration.

N A Nnalue1, A A Lindberg.   

Abstract

O-antigen-deficient derivatives of two mouse-virulent strains of Salmonella choleraesuis (serogroup C1; O-6,7) were constructed by transduction of a long deletion of the rfb operon. Strains SN36 and SN57 were derived from the smooth ancestor SL2824, while SN37 was derived from the smooth ancestor SL2840. These rfb deletion derivatives (rfb strains) had typical bacteriophage sensitivity patterns of "rough" Salmonella strains and were at least 200,000 times more sensitive to serum than their smooth ancestors. Lipopolysaccharides (LPS) extracted from them consisted only of two low-molecular-weight bands and lacked the ladderlike pattern of bands seen in the LPS of their smooth ancestors. The LPS from the rfb strains did not react in an enzyme immunoassay with any of three monoclonal antibodies directed against different epitopes of the O-6,7 antigen but reacted well with at least one of three monoclonal antibodies specific for core epitopes. The data were consistent with inability of these strains to synthesize O-specific chains and showed that the LPS extracted from SN57 was of chemotype Ra and that from SN36 was of chemotype Rb1, while that of SN37 consisted of a mixture of the two chemotypes. The virulence of these strains was tested by various routes in BALB/c mice. All three O-antigen-deficient derivatives were about as virulent as their "smooth" ancestors by the intraperitoneal and intravenous routes (50% lethal dose, 20 to 700 bacteria) but, unlike their ancestors, were avirulent by the oral route (50% lethal dose, greater than or equal to 5 x 10(9) bacteria). This suggests that the major role of smooth LPS in the mouse virulence of S. choleraesuis is to facilitate survival in the gastrointestinal tract and eventual entry into deeper tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695204      PMCID: PMC258846          DOI: 10.1128/iai.58.8.2493-2501.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse.

Authors:  H Saxén; I Reima; P H Mäkelä
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

2.  Invasion and lysis of HeLa cell monolayers by Salmonella typhi: the role of lipopolysaccharide.

Authors:  M J Mroczenski-Wildey; J L Di Fabio; F C Cabello
Journal:  Microb Pathog       Date:  1989-02       Impact factor: 3.738

3.  The effects of O-antigen character and enterobacterial common antigen content on the in vivo persistence of aromatic-dependent Salmonella sp. live-vaccine strains.

Authors:  N A Nnalue; B A Stocker
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

4.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

5.  In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant.

Authors:  J J Nevola; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.

Authors:  D M Hone; S R Attridge; B Forrest; R Morona; D Daniels; J T LaBrooy; R C Bartholomeusz; D J Shearman; J Hackett
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

7.  Efficient production of mouse and rat monoclonal antibodies against the O antigens of Salmonella serogroup C1, using LPS-coated bacteria as immunogen.

Authors:  J M Luk; N A Nnalue; A A Lindberg
Journal:  J Immunol Methods       Date:  1990-05-25       Impact factor: 2.303

8.  Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis.

Authors:  N A Nnalue; B A Stocker
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

9.  Colonization of the mouse intestine by an avirulent Salmonella typhimurium strain and its lipopolysaccharide-defective mutants.

Authors:  J J Nevola; B A Stocker; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer.

Authors:  B B Finlay; M N Starnbach; C L Francis; B A Stocker; S Chatfield; G Dougan; S Falkow
Journal:  Mol Microbiol       Date:  1988-11       Impact factor: 3.501

View more
  10 in total

Review 1.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

Review 2.  New technologies in using recombinant attenuated Salmonella vaccine vectors.

Authors:  Roy Curtiss; Wei Xin; Yuhua Li; Wei Kong; Soo-Young Wanda; Bronwyn Gunn; Shifeng Wang
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Study of the role of the htrB gene in Salmonella typhimurium virulence.

Authors:  B D Jones; W A Nichols; B W Gibson; M G Sunshine; M A Apicella
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar Typhimurium by human neutrophils.

Authors:  Robin van Bruggen; Debby Zweers; Angela van Diepen; Jaap T van Dissel; Dirk Roos; Arthur J Verhoeven; Taco W Kuijpers
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

5.  alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Pathogenicity of an Escherichia coli O115:K"V165" mutant negative for F165(1) fimbriae in septicemia of gnotobiotic pigs.

Authors:  M Ngeleka; M Jacques; B Martineau-Doizé; F Daigle; J Harel; J M Fairbrother
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.

Authors:  M Ngeleka; J Harel; M Jacques; J M Fairbrother
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swine.

Authors:  P J Fedorka-Cray; L C Kelley; T J Stabel; J T Gray; J A Laufer
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells.

Authors:  Claudia U Duerr; Sebastian F Zenk; Cécilia Chassin; Johanna Pott; Dominique Gütle; Michael Hensel; Mathias W Hornef
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.